ANATOLIAN JOURNAL OF CARDIOLOGY, cilt.16, sa.10, ss.734-741, 2016 (SCI-Expanded)
Objective: Data regarding stroke prevention strategies in non-valvular atrial fibrillation (NVAF) are limited to vitamin K antagonists (VKAs). This study aimed to evaluate real-life stroke prevention strategies for NVAF patients in the era of non-VKA oral anticoagulants (NOACs).